Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL

• G. Biolcati,
• S. Hanneken,
• E. I. Minder,
• N. J. Neumann,
• J. H. P. Wilson,
• P. J. Wolgen,
• D. J. Wright,
• A. J. Lloyd

Affiliations

G. Biolcati

Centre for Porphyrias, Istituto Dermatologico S. Gallicano - Istituti Fisioterapici Ospitalieri

S. Hanneken

Private Practice Empoderm

E. I. Minder

Stadtspital Triemli, Porphyria Outpatient Clinics

N. J. Neumann

Department of Dermatology, Heinrich Heine University

J. H. P. Wilson

The Department of Internal Medicine, Center of Lysosomal and Metabolic Diseases, Erasmus Medical Center

P. J. Wolgen

Clinuvel Pharmaceuticals Limited

D. J. Wright

Clinuvel Pharmaceuticals Limited

A. J. Lloyd

Acaster Lloyd Consulting Ltd